METHODS	A dose block-randomized , double-blind , placebo-controlled , parallel group study was performed in three groups with 10 subjects ( eight for active drug ; two for placebo ) per group ; each group received 200 , 400 or 600 mg of LC15-0444 once daily for 10 days .\